Melatonin, the darkness hormone, has been reported to be an antiproliferative agent that decreases PCNA expression in a hormone-dependent manner in vivo and in vitro in mice prostate tumors [66] and in female rat ovarian cells [67]. This evidence concerns the gene PCNA and prostate neoplasm.